• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初始经验性抗生素处方的调整及其对患者预后的影响:一家印度重症监护病房的经验

Modification of Initial Empirical Antibiotic Prescription and its Impact on Patient Outcome: Experience of an Indian Intensive Care Unit.

作者信息

Ghosh Supradip, Singh Amandeep, Lyall Aditya

机构信息

Department of Critical Care Medicine, Fortis-Escorts Hospital, Faridabad, Haryana, India.

出版信息

Indian J Crit Care Med. 2023 Aug;27(8):583-589. doi: 10.5005/jp-journals-10071-24505.

DOI:10.5005/jp-journals-10071-24505
PMID:37636855
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10452774/
Abstract

INTRODUCTION

Data on the overall impact of antibiotic modification following initial empiric prescription in both culture-positive and culture-negative critically ill patients are exiguous.

MATERIALS AND METHODS

In a retrospective analysis of "ANT-CRITIC" study, we classified ICU patients receiving empirical antibiotics who remained in the ICU for >72 hours or till availability of culture results (whichever is longer) into five groups based on culture results and antibiotic modification: negative culture, no change (group I), positive culture, no change (group II), positive culture, de-escalation (group III), positive culture, escalation (group IV) and negative culture, antibiotic modification (group V). Baseline variables and clinical outcomes were compared. Logistic regression analysis was performed to look for independent variables associated with mortality.

RESULTS

276 prescription episodes were analyzed. Group II was associated with worsening organ dysfunction at 72 hours, lower clinical cure rate at day 7, and higher hospital mortality. There was an independent association between group II prescription and hospital mortality [adjusted OR 2.774 (CI 1.178-6.533), = 0.02]. Group III received longer duration of antibiotic (mean duration = 8.27 ± 4.11 days, median duration = 7 days [IQR 5-11]).

CONCLUSION

Outcomes of critically ill infected patients differ significantly when they are classified based on culture result and antibiotic modification pattern.

HOW TO CITE THIS ARTICLE

Ghosh S, Singh A, Lyall A. Modification of Initial Empirical Antibiotic Prescription and its Impact on Patient Outcome: Experience of an Indian Intensive Care Unit. Indian J Crit Care Med 2023;27(8):583-589.

摘要

引言

关于在培养结果为阳性和阴性的重症患者中,初始经验性使用抗生素后进行抗生素调整的总体影响的数据非常稀少。

材料与方法

在对“ANT-CRITIC”研究的回顾性分析中,我们将接受经验性抗生素治疗且在重症监护病房(ICU)停留超过72小时或直至获得培养结果(以较长者为准)的ICU患者,根据培养结果和抗生素调整情况分为五组:培养结果阴性且未调整(第一组)、培养结果阳性且未调整(第二组)、培养结果阳性且降阶梯(第三组)、培养结果阳性且升阶梯(第四组)以及培养结果阴性且抗生素调整(第五组)。比较了基线变量和临床结局。进行逻辑回归分析以寻找与死亡率相关的独立变量。

结果

分析了276个处方事件。第二组与72小时时器官功能障碍恶化、第7天临床治愈率较低以及医院死亡率较高相关。第二组处方与医院死亡率之间存在独立关联[调整后的比值比为2.774(置信区间1.178-6.533),P = 0.02]。第三组接受抗生素治疗的时间更长(平均疗程 = 8.27 ± 4.11天,中位疗程 = 7天[四分位间距5-11])。

结论

根据培养结果和抗生素调整模式对重症感染患者进行分类时,其结局存在显著差异。

如何引用本文

戈什S,辛格A,莱尔A。初始经验性抗生素处方的调整及其对患者结局的影响:一家印度重症监护病房的经验。《印度重症医学杂志》2023;27(8):583-589。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8c9/10452774/417c47a49761/ijccm-27-583-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8c9/10452774/417c47a49761/ijccm-27-583-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8c9/10452774/417c47a49761/ijccm-27-583-g001.jpg

相似文献

1
Modification of Initial Empirical Antibiotic Prescription and its Impact on Patient Outcome: Experience of an Indian Intensive Care Unit.初始经验性抗生素处方的调整及其对患者预后的影响:一家印度重症监护病房的经验
Indian J Crit Care Med. 2023 Aug;27(8):583-589. doi: 10.5005/jp-journals-10071-24505.
2
New Antibiotic Prescription Pattern in Critically Ill Patients ("Ant-critic"): Prospective Observational Study from an Indian Intensive Care Unit.危重症患者的新型抗生素处方模式(“Ant-critic”):来自印度重症监护病房的前瞻性观察研究。
Indian J Crit Care Med. 2022 Dec;26(12):1275-1284. doi: 10.5005/jp-journals-10071-24366.
3
Audit of Antibiotic Practices: An Experience from a Tertiary Referral Center.抗生素使用情况审计:来自三级转诊中心的经验
Indian J Crit Care Med. 2019 Jan;23(1):7-10. doi: 10.5005/jp-journals-10071-23104.
4
The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?降钙素原作为脓毒症管理中生物标志物的功效:屠龙之举还是徒劳无功?
Surg Infect (Larchmt). 2013 Dec;14(6):489-511. doi: 10.1089/sur.2012.028. Epub 2013 Nov 25.
5
Safety and Feasibility of Antibiotic De-escalation in Critically Ill Children With Sepsis - A Prospective Analytical Study From a Pediatric ICU.脓毒症重症患儿抗生素降阶梯治疗的安全性与可行性——一项来自儿科重症监护病房的前瞻性分析研究
Front Pediatr. 2021 Mar 8;9:640857. doi: 10.3389/fped.2021.640857. eCollection 2021.
6
Serum Procalcitonin as a Biomarker to Determine the Duration of Antibiotic Therapy in Adult Patients with Sepsis and Septic Shock in Intensive Care Units: A Prospective Study.血清降钙素原作为确定重症监护病房中成年脓毒症和脓毒性休克患者抗生素治疗疗程的生物标志物:一项前瞻性研究。
Indian J Crit Care Med. 2021 May;25(5):507-511. doi: 10.5005/jp-journals-10071-23802.
7
[Analysis of clinical features and risk factors for mortality in patients with culture-negative sepsis: a single-center retrospective cohort study based on MIMIC-IV].血培养阴性脓毒症患者的临床特征及死亡危险因素分析:一项基于MIMIC-IV的单中心回顾性队列研究
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Oct;33(10):1181-1186. doi: 10.3760/cma.j.cn121430-20210525-00780.
8
Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.大学医院医学重症监护病房314例脓毒症发作的生存分析:重症监护病房性能及抗菌治疗的影响
Croat Med J. 2006 Jun;47(3):385-97.
9
Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study.降阶梯使用β-内酰胺类抗生素对 ICU 患者抗生素耐药性产生的影响:一项回顾性观察研究。
Intensive Care Med. 2016 Jun;42(6):1029-39. doi: 10.1007/s00134-016-4301-z. Epub 2016 Mar 30.
10
De-Escalation of Antibiotics Does Not Increase Mortality in Critically Ill Surgical Patients.外科重症患者抗生素降阶梯治疗不会增加死亡率。
Surg Infect (Larchmt). 2016 Feb;17(1):48-52. doi: 10.1089/sur.2014.202. Epub 2015 Dec 29.

引用本文的文献

1
Risk factors for the prognostic effects of patients with pelvic abscesses: a clinical retrospective study.盆腔脓肿患者预后影响的危险因素:一项临床回顾性研究。
BMC Womens Health. 2025 Jun 4;25(1):276. doi: 10.1186/s12905-025-03838-5.

本文引用的文献

1
New Antibiotic Prescription Pattern in Critically Ill Patients ("Ant-critic"): Prospective Observational Study from an Indian Intensive Care Unit.危重症患者的新型抗生素处方模式(“Ant-critic”):来自印度重症监护病房的前瞻性观察研究。
Indian J Crit Care Med. 2022 Dec;26(12):1275-1284. doi: 10.5005/jp-journals-10071-24366.
2
Characteristics and clinical outcomes of culture-negative and culture-positive septic shock: a single-center retrospective cohort study.培养阴性和培养阳性脓毒性休克的特征和临床结局:一项单中心回顾性队列研究。
Crit Care. 2021 Jan 6;25(1):11. doi: 10.1186/s13054-020-03421-4.
3
Systematic review of the impact of appropriate versus inappropriate initial antibiotic therapy on outcomes of patients with severe bacterial infections.
系统评价适当与不适当初始抗生素治疗对严重细菌感染患者结局的影响。
Int J Antimicrob Agents. 2020 Dec;56(6):106184. doi: 10.1016/j.ijantimicag.2020.106184. Epub 2020 Oct 9.
4
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study.危重症患者的抗菌药物降阶梯治疗和临床治愈评估:DIANA 研究。
Intensive Care Med. 2020 Jul;46(7):1404-1417. doi: 10.1007/s00134-020-06111-5. Epub 2020 Jun 9.
5
Antimicrobial de-escalation as part of antimicrobial stewardship in intensive care: no simple answers to simple questions-a viewpoint of experts.抗菌药物降级作为重症监护中抗菌药物管理的一部分:没有简单的答案可以解决简单的问题——专家观点。
Intensive Care Med. 2020 Feb;46(2):236-244. doi: 10.1007/s00134-019-05871-z. Epub 2020 Feb 5.
6
Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP).危重症患者的抗菌药物降阶梯治疗:欧洲重症监护医学学会(ESICM)和欧洲临床微生物学和传染病学会(ESCMID)危重症患者研究小组(ESGCIP)的一个工作组的立场声明。
Intensive Care Med. 2020 Feb;46(2):245-265. doi: 10.1007/s00134-019-05866-w. Epub 2019 Nov 28.
7
Duration of Exposure to Antipseudomonal β-Lactam Antibiotics in the Critically Ill and Development of New Resistance.重症患者接触抗假单胞菌β-内酰胺类抗生素的时间与新耐药性的产生。
Pharmacotherapy. 2019 Mar;39(3):261-270. doi: 10.1002/phar.2201. Epub 2019 Jan 7.
8
Culture-Negative Severe Sepsis: Nationwide Trends and Outcomes.血培养阴性的严重脓毒症:全国性趋势及结果
Chest. 2016 Dec;150(6):1251-1259. doi: 10.1016/j.chest.2016.08.1460. Epub 2016 Sep 9.
9
Antibiotic de-escalation: observational causal inference and culture dependence.抗生素降阶梯治疗:观察性因果推断与培养依赖性
Intensive Care Med. 2016 Oct;42(10):1647-1648. doi: 10.1007/s00134-016-4443-z. Epub 2016 Jul 18.
10
Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study.降阶梯使用β-内酰胺类抗生素对 ICU 患者抗生素耐药性产生的影响:一项回顾性观察研究。
Intensive Care Med. 2016 Jun;42(6):1029-39. doi: 10.1007/s00134-016-4301-z. Epub 2016 Mar 30.